Skip to main content
Erschienen in: Journal of Neural Transmission 4/2009

01.04.2009 | Dementias - Short Communication

Auricular vagus somatosensory evoked potentials in vascular dementia

verfasst von: Thomas Polak, Falko Markulin, Ann-Christine Ehlis, Florian Metzger, Julia B. Langer, Thomas M. Ringel, Andreas J. Fallgatter

Erschienen in: Journal of Neural Transmission | Ausgabe 4/2009

Einloggen, um Zugang zu erhalten

Abstract

A new method for the assessment of vagus nerve function has recently been introduced into clinical practice. In the present study we could show that, contrary to our results in Alzheimer’s disease (AD), in patients with vascular dementia (VaD) vagus sensory evoked potentials (VSEP) did not show statistically significant differences as compared to healthy controls. Thus, we hypothesize that the new method of VSEP could possibly contribute to a differential diagnosis between early cases of AD and VaD.
Literatur
Zurück zum Zitat Beach TG, Wilson JR, Sue LI, Newell A, Poston M, Cisneros R, Pandya Y, Esh C, Connor DJ, Sabbagh, Walker DG, Roher AE (2007) Circle of Willis atherosclerosis: association with Alzheimer’s disease, neuritic plaques and neurofibrillary tangles. Acta Neuropathol (Berl) 113:13–21CrossRef Beach TG, Wilson JR, Sue LI, Newell A, Poston M, Cisneros R, Pandya Y, Esh C, Connor DJ, Sabbagh, Walker DG, Roher AE (2007) Circle of Willis atherosclerosis: association with Alzheimer’s disease, neuritic plaques and neurofibrillary tangles. Acta Neuropathol (Berl) 113:13–21CrossRef
Zurück zum Zitat Bjelik A, Pakaski M, Bereczki E, Gonda S, Juhasz A, Rimanoczy A, Zana M, Janka Z, Santha M, Kalman J (2007) APP mRNA splicing is upregulated in the brain of biglycan transgenic mice. Neurochem Int 50:1–4PubMedCrossRef Bjelik A, Pakaski M, Bereczki E, Gonda S, Juhasz A, Rimanoczy A, Zana M, Janka Z, Santha M, Kalman J (2007) APP mRNA splicing is upregulated in the brain of biglycan transgenic mice. Neurochem Int 50:1–4PubMedCrossRef
Zurück zum Zitat Braaten AJ, Parsons TD, McCue R, Sellers A, Burns WJ (2006) Neurocognitive differential diagnosis of dementing diseases: Alzheimer’s Dementia, Vascular Dementia, Frontotemporal Dementia, and Major Depressive Disorder. Int J Neurosci 116:1271–1293PubMedCrossRef Braaten AJ, Parsons TD, McCue R, Sellers A, Burns WJ (2006) Neurocognitive differential diagnosis of dementing diseases: Alzheimer’s Dementia, Vascular Dementia, Frontotemporal Dementia, and Major Depressive Disorder. Int J Neurosci 116:1271–1293PubMedCrossRef
Zurück zum Zitat Cacabelos R (2004) Genomic characterization of Alzheimer’s disease and genotype-related phenotypic analysis of biological markers in dementia. Pharmacogenomics 5:1049–1105PubMedCrossRef Cacabelos R (2004) Genomic characterization of Alzheimer’s disease and genotype-related phenotypic analysis of biological markers in dementia. Pharmacogenomics 5:1049–1105PubMedCrossRef
Zurück zum Zitat Chiappa KH (1983) Evoked potentials in clinical medicine. Raven Press, New York Chiappa KH (1983) Evoked potentials in clinical medicine. Raven Press, New York
Zurück zum Zitat Court JA, Perry EK (2003) Neurotransmitter abnormalities in vascular dementia. Int Psychogeriatr 15(Suppl 1):81–87PubMedCrossRef Court JA, Perry EK (2003) Neurotransmitter abnormalities in vascular dementia. Int Psychogeriatr 15(Suppl 1):81–87PubMedCrossRef
Zurück zum Zitat Demaerschalk BM, Wingerchuk DM (2007) Treatment of vascular dementia and vascular cognitive impairment. Neurologist 13:37–41PubMedCrossRef Demaerschalk BM, Wingerchuk DM (2007) Treatment of vascular dementia and vascular cognitive impairment. Neurologist 13:37–41PubMedCrossRef
Zurück zum Zitat Drechsler F, Neuhauser B (1986) Somatosensory trigeminal evoked potentials in normal subjects and in patients with trigeminal neuralgia before and after thermocoagulation of the Ganglion gasseri. Electromyogr Clin Neurophysiol 26:315–326PubMed Drechsler F, Neuhauser B (1986) Somatosensory trigeminal evoked potentials in normal subjects and in patients with trigeminal neuralgia before and after thermocoagulation of the Ganglion gasseri. Electromyogr Clin Neurophysiol 26:315–326PubMed
Zurück zum Zitat Fallgatter AJ, Neuhauser B, Herrmann MJ, Ehlis AC, Wagener A, Scheuerpflug P, Reiners K, Riederer P (2003) Far field potentials from the brainstem after transcutaneous vagus nerve stimulation. J Neural Trans 110:1437–1443CrossRef Fallgatter AJ, Neuhauser B, Herrmann MJ, Ehlis AC, Wagener A, Scheuerpflug P, Reiners K, Riederer P (2003) Far field potentials from the brainstem after transcutaneous vagus nerve stimulation. J Neural Trans 110:1437–1443CrossRef
Zurück zum Zitat Fallgatter AJ, Ehlis AC, Ringel TM, Herrmann MJ (2005) Age-effect on far field potentials from the brainstem after transcutaneous vagus nerve stimulation. Int J Psychophysiol 56:37–43PubMedCrossRef Fallgatter AJ, Ehlis AC, Ringel TM, Herrmann MJ (2005) Age-effect on far field potentials from the brainstem after transcutaneous vagus nerve stimulation. Int J Psychophysiol 56:37–43PubMedCrossRef
Zurück zum Zitat Faul F, Erdfelder E, Lang AG, Buchner A (2007) G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 39:175–191PubMed Faul F, Erdfelder E, Lang AG, Buchner A (2007) G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 39:175–191PubMed
Zurück zum Zitat Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, Hall K, Hasegawa K, Hendrie H, Huang Y, Jorm A, Mathers C, Rimmer E, Scazufca M, Alzheimer’s Disease International (2005) Global prevalence of dementia: a Delphi consensus study. Lancet 366:2112–2117 Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, Hall K, Hasegawa K, Hendrie H, Huang Y, Jorm A, Mathers C, Rimmer E, Scazufca M, Alzheimer’s Disease International (2005) Global prevalence of dementia: a Delphi consensus study. Lancet 366:2112–2117
Zurück zum Zitat Folstein MF, Folstein SE, McHugh PR (1975) “Mini Mental State”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198PubMedCrossRef Folstein MF, Folstein SE, McHugh PR (1975) “Mini Mental State”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198PubMedCrossRef
Zurück zum Zitat Hanyu H, Shimizu S, Tanaka Y, Hirao K, Iwamoto T, Abe K (2007) MR features of the substantia innominata and therapeutic implications in dementias. Neurobiol Aging 28:548–554PubMedCrossRef Hanyu H, Shimizu S, Tanaka Y, Hirao K, Iwamoto T, Abe K (2007) MR features of the substantia innominata and therapeutic implications in dementias. Neurobiol Aging 28:548–554PubMedCrossRef
Zurück zum Zitat Hentschel F, Supprian T, Frolich L (2005) Alzheimer’s disease versus vascular dementia—dichotomy or interaction? Fortschr Neurol Psychiatr 73:317–326PubMedCrossRef Hentschel F, Supprian T, Frolich L (2005) Alzheimer’s disease versus vascular dementia—dichotomy or interaction? Fortschr Neurol Psychiatr 73:317–326PubMedCrossRef
Zurück zum Zitat Hentschel F, Damian M, Krumm B, Froelich L (2007) White matter lesions—age-adjusted values for cognitively healthy and demented subjects. Acta Neurol Scand 115:174–180PubMedCrossRef Hentschel F, Damian M, Krumm B, Froelich L (2007) White matter lesions—age-adjusted values for cognitively healthy and demented subjects. Acta Neurol Scand 115:174–180PubMedCrossRef
Zurück zum Zitat Jaspers HH (1958) Report of the committee on methods of clinical examination in electroencephylography. Electroencephalogr Clin Neurophysiol 10:370–371CrossRef Jaspers HH (1958) Report of the committee on methods of clinical examination in electroencephylography. Electroencephalogr Clin Neurophysiol 10:370–371CrossRef
Zurück zum Zitat Jellinger KA (2004) Pathology and pathophysiology of vascular cognitive impairment. A critical update. Panminerva Med 46:217–226 Jellinger KA (2004) Pathology and pathophysiology of vascular cognitive impairment. A critical update. Panminerva Med 46:217–226
Zurück zum Zitat Jellinger KA (2005) Understanding the pathology of vascular cognitive impairment. J Neurol Sci 229–230:57–63PubMedCrossRef Jellinger KA (2005) Understanding the pathology of vascular cognitive impairment. J Neurol Sci 229–230:57–63PubMedCrossRef
Zurück zum Zitat Jellinger KA (2007) The enigma of vascular cognitive disorder and vascular dementia. Acta Neuropathol (Berl) 113:349–388CrossRef Jellinger KA (2007) The enigma of vascular cognitive disorder and vascular dementia. Acta Neuropathol (Berl) 113:349–388CrossRef
Zurück zum Zitat Loeb C, Meyer JS (2000) Criteria for diagnosis of vascular dementia. Arch Neurol 57:1382–1383PubMedCrossRef Loeb C, Meyer JS (2000) Criteria for diagnosis of vascular dementia. Arch Neurol 57:1382–1383PubMedCrossRef
Zurück zum Zitat Onishi J, Suzuki Y, Yoshiko K, Hibino S, Iguchi A (2005) Predictive model for assessing cognitive impairment by quantitative electroencephalography. Cogn Behav Neurol 18:179–184PubMedCrossRef Onishi J, Suzuki Y, Yoshiko K, Hibino S, Iguchi A (2005) Predictive model for assessing cognitive impairment by quantitative electroencephalography. Cogn Behav Neurol 18:179–184PubMedCrossRef
Zurück zum Zitat Parvizi J, Van Hoesen GW, Damasio A (2001) The selective vulnerability of brain stem nuclei to Alzheimer’s disease. Ann Neurol 49:53–66PubMedCrossRef Parvizi J, Van Hoesen GW, Damasio A (2001) The selective vulnerability of brain stem nuclei to Alzheimer’s disease. Ann Neurol 49:53–66PubMedCrossRef
Zurück zum Zitat Perry E, Ziabreva I, Perry R, Aarsland D, Ballard C (2005) Absence of cholinergic deficits in “pure” vascular dementia. Neurology 64:132–133PubMed Perry E, Ziabreva I, Perry R, Aarsland D, Ballard C (2005) Absence of cholinergic deficits in “pure” vascular dementia. Neurology 64:132–133PubMed
Zurück zum Zitat Peukert ET, Filler TJ (2002) The nerve supply of the human auricle. Clin Anatom 15:35–37CrossRef Peukert ET, Filler TJ (2002) The nerve supply of the human auricle. Clin Anatom 15:35–37CrossRef
Zurück zum Zitat Picton TW, Hillyard SA, Krausz HI, Galambos R (1974) Human auditory evoked potentials: I. Evaluation of components. Electroencephalogr Clin Neurophysiol 36:179–190PubMedCrossRef Picton TW, Hillyard SA, Krausz HI, Galambos R (1974) Human auditory evoked potentials: I. Evaluation of components. Electroencephalogr Clin Neurophysiol 36:179–190PubMedCrossRef
Zurück zum Zitat Pirchl M, Marksteiner J, Humpel C (2006) Effects of acidosis on brain capillary endothelial cells and cholinergic neurons: relevance to vascular dementia and Alzheimer’s disease. Neurol Res 28:657–664PubMedCrossRef Pirchl M, Marksteiner J, Humpel C (2006) Effects of acidosis on brain capillary endothelial cells and cholinergic neurons: relevance to vascular dementia and Alzheimer’s disease. Neurol Res 28:657–664PubMedCrossRef
Zurück zum Zitat Polak T, Ehlis AC, Langer J, Plichta M, Metzger F, Ringel TM, Fallgatter AJ (2007) Non-invasive measurement of vagus activity in the brainstem—a methodological progress towards earlier diagnosis of dementias? J Neural Transm 110:1437–1443 Polak T, Ehlis AC, Langer J, Plichta M, Metzger F, Ringel TM, Fallgatter AJ (2007) Non-invasive measurement of vagus activity in the brainstem—a methodological progress towards earlier diagnosis of dementias? J Neural Transm 110:1437–1443
Zurück zum Zitat Reed BR, Mungas DM, Kramer JH, Ellis W, Vinters HV, Zarow C, Jagust WJ, Chui HC (2007) Profiles of neuropsychological impairment in autopsy-defined Alzheimer’s disease and cerebrovascular disease. Brain 130:731–739PubMedCrossRef Reed BR, Mungas DM, Kramer JH, Ellis W, Vinters HV, Zarow C, Jagust WJ, Chui HC (2007) Profiles of neuropsychological impairment in autopsy-defined Alzheimer’s disease and cerebrovascular disease. Brain 130:731–739PubMedCrossRef
Zurück zum Zitat Roman GC (2004) Vascular dementia. Advances in nosology, diagnosis, treatment and prevention. Panminerva Med 46:207–215PubMed Roman GC (2004) Vascular dementia. Advances in nosology, diagnosis, treatment and prevention. Panminerva Med 46:207–215PubMed
Zurück zum Zitat Roman GC, Kalaria RN (2006) Vascular determinants of cholinergic deficits in Alzheimer disease and vascular dementia. Neurobiol Aging 27:1769–1785PubMedCrossRef Roman GC, Kalaria RN (2006) Vascular determinants of cholinergic deficits in Alzheimer disease and vascular dementia. Neurobiol Aging 27:1769–1785PubMedCrossRef
Zurück zum Zitat Roy S, Rauk A (2005) Alzheimer’s disease and the ‘ABSENT’ hypothesis: mechanism for amyloid beta endothelial and neuronal toxicity. Med Hypotheses 65:123–137PubMedCrossRef Roy S, Rauk A (2005) Alzheimer’s disease and the ‘ABSENT’ hypothesis: mechanism for amyloid beta endothelial and neuronal toxicity. Med Hypotheses 65:123–137PubMedCrossRef
Zurück zum Zitat Sadowski M, Pankiewicz J, Scholtzova H, Li YS, Quartermain D, Duff K, Wisniewski T (2004) Links between the pathology of Alzheimer’s disease and vascular dementia. Neurochem Res 29:1257–1266PubMedCrossRef Sadowski M, Pankiewicz J, Scholtzova H, Li YS, Quartermain D, Duff K, Wisniewski T (2004) Links between the pathology of Alzheimer’s disease and vascular dementia. Neurochem Res 29:1257–1266PubMedCrossRef
Zurück zum Zitat Shields RW Jr (1993) Functional anatomy of the autonomic nervous system. J Clin Neurophysiol 10(1):2–13 Shields RW Jr (1993) Functional anatomy of the autonomic nervous system. J Clin Neurophysiol 10(1):2–13
Zurück zum Zitat Stechison MT (1993) The trigeminal evoked potential: Part II. Intraoperative recording of short latency responses. Neurosurgery 33:639–644PubMedCrossRef Stechison MT (1993) The trigeminal evoked potential: Part II. Intraoperative recording of short latency responses. Neurosurgery 33:639–644PubMedCrossRef
Zurück zum Zitat Thal DR, Rüb U, Orantes M, Braak H (2002) Phases of Aβ-deposition in the human brain and its relevance for the development of AD. Neurology 58:1791–1800PubMed Thal DR, Rüb U, Orantes M, Braak H (2002) Phases of Aβ-deposition in the human brain and its relevance for the development of AD. Neurology 58:1791–1800PubMed
Zurück zum Zitat Tomimoto H, Ohtani R, Shibata M, Nakamura N, Ihara M (2005) Loss of cholinergic pathways in vascular dementia of the Binswanger type. Dement Geriatr Cogn Disord 19:282–288PubMedCrossRef Tomimoto H, Ohtani R, Shibata M, Nakamura N, Ihara M (2005) Loss of cholinergic pathways in vascular dementia of the Binswanger type. Dement Geriatr Cogn Disord 19:282–288PubMedCrossRef
Zurück zum Zitat Van der Flier WM, Barkhof F, Scheltens P (2007) Shifting paradigms in dementia: toward stratification of diagnosis and treatment using MRI. Ann N Y Acad Sci 1097:215–224PubMedCrossRef Van der Flier WM, Barkhof F, Scheltens P (2007) Shifting paradigms in dementia: toward stratification of diagnosis and treatment using MRI. Ann N Y Acad Sci 1097:215–224PubMedCrossRef
Zurück zum Zitat Van Harten B, Laman DM, van Duijn H, Knol DL, Stam CJ, Scheltens P, Weinstein HC (2006) The auditory oddball paradigm in patients with vascular cognitive impairment: a prolonged latency of the N2 complex. Dement Geriatr Cogn Disord 21:322–327PubMedCrossRef Van Harten B, Laman DM, van Duijn H, Knol DL, Stam CJ, Scheltens P, Weinstein HC (2006) The auditory oddball paradigm in patients with vascular cognitive impairment: a prolonged latency of the N2 complex. Dement Geriatr Cogn Disord 21:322–327PubMedCrossRef
Zurück zum Zitat Von Bernhardi R, Alarcon R, Mezzano D, Fuentes P, Inestrosa NC (2005) Blood cells cholinesterase activity in early stage Alzheimer’s disease and vascular dementia. Dement Geriatr Cogn Disord 19:204–212CrossRef Von Bernhardi R, Alarcon R, Mezzano D, Fuentes P, Inestrosa NC (2005) Blood cells cholinesterase activity in early stage Alzheimer’s disease and vascular dementia. Dement Geriatr Cogn Disord 19:204–212CrossRef
Zurück zum Zitat Weller RO, Cohen NR, Nicoll JA (2004) Cerebrovascular disease and the pathophysiology of Alzheimer’s disease. Implications for therapy. Panminerva Med 46:239–251 Weller RO, Cohen NR, Nicoll JA (2004) Cerebrovascular disease and the pathophysiology of Alzheimer’s disease. Implications for therapy. Panminerva Med 46:239–251
Metadaten
Titel
Auricular vagus somatosensory evoked potentials in vascular dementia
verfasst von
Thomas Polak
Falko Markulin
Ann-Christine Ehlis
Florian Metzger
Julia B. Langer
Thomas M. Ringel
Andreas J. Fallgatter
Publikationsdatum
01.04.2009
Verlag
Springer Vienna
Erschienen in
Journal of Neural Transmission / Ausgabe 4/2009
Print ISSN: 0300-9564
Elektronische ISSN: 1435-1463
DOI
https://doi.org/10.1007/s00702-009-0202-4

Weitere Artikel der Ausgabe 4/2009

Journal of Neural Transmission 4/2009 Zur Ausgabe

Biological Psychiatry - Original Article

Neuregulin 1 and age of onset in the major psychoses

Basic Neurosciences, Genetics and Immunology - Original Article

Experience with long-term treatment with albumin-supplemented botulinum toxin type A

Basic Neurosciences, Genetics and Immunology - Original Article

Lamotrigine and valproic acid have different effects on motorcortical neuronal excitability

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.